The effects of ultrasound and arsenic trioxide on neurogliocytoma cells and secondary activation of macrophages

Tumori

Volumn 95, Issue 6, 2009, Pages 780-788

  Xu, Yonggang ^a   Zhang, Yafang ^a   Liu, Xiaoqian ^a   Wang, Zhi ^a   Ma, Jing ^a   Wang, Jie ^b   Yue, Wu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Cell death; Macrophage; Neurogliocytoma; Ultrasound

Indexed keywords

ARSENIC TRIOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL LEVEL; CELL STIMULATION; ENZYME RELEASE; GLIOMA CELL; MACROPHAGE ACTIVATION; MALE; NEUROGLIOCYTOMA CELL; NONHUMAN; PROTEIN SECRETION; RAT; ULTRASOUND THERAPY;

EID: 76349095796     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500622     Document Type: Article

References (33)

1. Ulutin C: Chemoradiotherapy in high-grade gliomas. Tumori, 93: 526, 2007.
2. Martinez R, Schackert G: Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment. Epigenetics, 2: 147-150, 2007.
3. Tang W, Liu Q, Wang X, Wang R Cao B, Mi N, Zhang J: Involvement of Caspase 8 in apoptosis induced by ultrasound-activated hematoporphyrin in sarcoma 180 cells in vitro. J Ultrasound Med, 27: 645-656, 2008.
4. Postema M, Gilja OH: Ultrasound-directed drug delivery. Curr Pharm Biotechnol, 8: 355-361, 2004.
5. Paolo DD, Pastorino F, Brignole C, Marimpietri D, Loi M, Ponzoni M, Pagnan G: Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment. Tumori, 94: 246-253, 2008.
6. Deckers R, Rome C, Moonen CT: The role of ultrasound and magnetic resonance in local drug delivery. J Magn Reson Imaging, 27: 400-409, 2008.
7. Wang ZY, Chen Z: Acute promyelocyte leukemia: from highly fatal to highly curable. Blood, 111: 2505-2515, 2008.
8. Mervis J: Ancient remedy performs new tricks. Science, 273: 578, 1996.
9. Ishitsuka K, Tamura K: Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur J Haematol, 80: 185-196, 2008.
10. Lin CC, Hsu C, Hsu CH, Hsu WL, Cheng AL, Yang CH: Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial. Invest New Drugs, 25: 77-84, 2007.
11. Cai J, Niu X, Chen Y, Hu Q, Shi G, Wu H, Wang J, Yi J: Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia, 10: 41-51, 2008.
12. Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS: Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Cancer Res, 68: 266-275, 2008.
13. Savill J, Fadok V: Corpse clearance defines the meaning of cell death. Nature, 407: 784-788, 2000.
14. Siu T, Jackson J, Burt H, Chiao M: Drug uptake enhancement using sonodynamic effects at 4 MHz-a potential application for micro-ultrasonic- Transducers. IEEE Trans Biomed Eng, 54: 1153-1156, 2007.
15. Yu T, Huang X, Hu K, Bai J, Wang Z: Mechanisms of reversal of adriamycin resistance in human ovarian carcinoma cell line by ultrasound. Int J Gynecol Cancer, 14: 76-81, 2004.
16. Schneider M: Molecular imaging and ultrasound-assisted drug delivery. J Endourol, 22: 795-802, 2008.
17. Zhao M, Xue DB, Zheng B, Zhang WH, Pan SH, Sun B: Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis. World J Gastroenterol, 13: 5612-5617, 2007.
18. Kern JC, Kehrer JP: Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact, 139: 79-95, 2002.
19. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci, 13: 453-461, 2008.
20. Mantovani A, Schioppa T, Biswas SK, Marchesi F, Allavena P, Sica A: Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations. Tumori, 89: 459-468, 2003.
21. Bingle L, Brown NJ, Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol, 196: 254-265, 2002.
22. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S: Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep, 14: 425-431, 2005.
23. Stearman RS, Dwyer-Nield L, Grady MC, Malkinson AM, Geraci MW: A macrophage gene expression signature defines a field effect in the lung tumor microenvironment. Cancer Res, 68: 34-43, 2008.
24. Sun J, Turner A, Xu J, Grönberg H, Isaacs W: Genetic variability in inflammation pathways and prostate cancer risk. Urol Oncol, 25: 250-259, 2007.
25. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M: IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118: 285-296, 2004.
26. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R: Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest, 116: 2132-2141, 2006.
27. Yang L, Tao LY, Chen XP: Roles of NF-kappaB in central nervous system damage and repair. Neurosci Bull, 23: 307-313, 2007.
28. Sarkar FH, Li Y: NF-kappaB: a potential target for cancer chemoprevention and therapy. Front Biosci, 13: 2950-2959, 2008.
29. Porta C, Subhra Kumar B, Larghi P, Rubino L, Mancino A, Sica A: Tumor promotion by tumor-associated macrophages. Adv Exp Med Biol, 604: 67-86, 2007.
30. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH: Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res, 63: 4181-4187, 2003.
31. Saif MW, Black G, Roy S, Bell D, Russo S, Eloubeidi MA, Steg A, Johnson MR, Zelterman D, Diasio RB: Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine Phosphorylase. Cancer J, 13: 247-256, 2007.
32. Kim JS, Kim JG, Moon MY, Jeon CY, Won HY, Kim HJ, Jeon YJ, Seo JY, Kim JI, Kim J, Lee JY, Kim PH, Park JB: Transforming growth factor-beta1 regulates macrophage migration via RhoA. Blood, 108: 1821-1829, 2006.
33. Quaranta M, Divella R, Daniele A, Di Tardo S, Venneri MT, Lolli I, Troccoli G: Epidemal growth factor receptor serum levels and prognostic value in malignant gliomas. Tumori, 93: 275-280, 2007.